Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | euchromatic histone-lysine N-methyltransferase 2 | Starlite/ChEMBL | No references |
Homo sapiens | v-ets avian erythroblastosis virus E26 oncogene homolog | Starlite/ChEMBL | No references |
Species | Potential target | Known druggable target/s | Ortholog Group |
---|---|---|---|
Schistosoma mansoni | ets-related | Get druggable targets OG5_131947 | All targets in OG5_131947 |
Brugia malayi | Pre-SET motif family protein | Get druggable targets OG5_131470 | All targets in OG5_131470 |
Onchocerca volvulus | Get druggable targets OG5_131470 | All targets in OG5_131470 | |
Loa Loa (eye worm) | fli-1 protein | Get druggable targets OG5_131947 | All targets in OG5_131947 |
Schistosoma japonicum | ko:K09435 transcriptional regulator ERG, putative | Get druggable targets OG5_131947 | All targets in OG5_131947 |
Brugia malayi | Fli-1 protein | Get druggable targets OG5_131947 | All targets in OG5_131947 |
Loa Loa (eye worm) | pre-SET domain-containing protein family protein | Get druggable targets OG5_131470 | All targets in OG5_131470 |
Trichomonas vaginalis | set domain proteins, putative | Get druggable targets OG5_131470 | All targets in OG5_131470 |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Schistosoma mansoni | serine/threonine protein kinase | 0.0393 | 1 | 1 |
Trichomonas vaginalis | set domain proteins, putative | 0.0286 | 0.7016 | 0.5 |
Schistosoma mansoni | ets-related | 0.0265 | 0.6442 | 0.6429 |
Echinococcus multilocularis | GA binding protein alpha chain | 0.0087 | 0.1472 | 0.144 |
Loa Loa (eye worm) | fli-1 protein | 0.0265 | 0.6442 | 0.6429 |
Loa Loa (eye worm) | camk/mapkapk/mapkapk protein kinase | 0.0393 | 1 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0075 | 0.1118 | 0.1085 |
Plasmodium vivax | SET domain protein, putative | 0.0036 | 0.0037 | 0.5 |
Echinococcus granulosus | histone lysine methyltransferase setb | 0.0036 | 0.0037 | 0.0037 |
Loa Loa (eye worm) | pre-SET domain-containing protein family protein | 0.0251 | 0.6047 | 0.6032 |
Toxoplasma gondii | histone lysine methyltransferase SET/SUV39 | 0.0036 | 0.0037 | 0.5 |
Onchocerca volvulus | 0.0286 | 0.7016 | 1 | |
Brugia malayi | Fli-1 protein | 0.0265 | 0.6442 | 0.6429 |
Echinococcus granulosus | MAP kinase activated protein kinase 2 | 0.0393 | 1 | 1 |
Schistosoma mansoni | gabp alpha | 0.0087 | 0.1472 | 0.144 |
Echinococcus granulosus | GA binding protein alpha chain | 0.0087 | 0.1472 | 0.1472 |
Brugia malayi | Ets-domain containing protein | 0.0087 | 0.1472 | 0.144 |
Brugia malayi | Ets-domain containing protein | 0.0087 | 0.1472 | 0.144 |
Loa Loa (eye worm) | D-ets-4 DNA binding domain-containing protein | 0.0087 | 0.1472 | 0.144 |
Brugia malayi | Pre-SET motif family protein | 0.0251 | 0.6047 | 0.6032 |
Echinococcus multilocularis | MAP kinase activated protein kinase 2 | 0.0393 | 1 | 1 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Potency (functional) | 1 uM | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Histone Lysine Methyltransferase G9a. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504404] | ChEMBL. | No reference |
Potency (functional) | 11.2202 uM | PubChem BioAssay. qHTS for Small Molecule Inhibitors of the ERG Ets/DNA interaction. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (binding) | = 28.1838 um | PUBCHEM_BIOASSAY: qHTS for Inhibitors of Tau Fibril Formation, Thioflavin T Binding. (Class of assay: confirmatory) [Related pubchem assays: 596 ] | ChEMBL. | No reference |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.